Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pear Therapeutics

Pear Therapeutics
2013 FOUNDED
PRIVATE STATUS
71-80 EMPLOYEES
Series C LATEST DEAL TYPE
$64M LATEST DEAL AMOUNT
11 INVESTORS
Description

Developer of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payors.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Outcome Management (Healthcare)
Application Software
Primary Office
  • 200 State Street
  • 13th Floor
  • Boston, MA 02109
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pear Therapeutics’s full profile, request a free trial.

Pear Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 04-Jan-2019 $64M 00000 00000 Completed Generating Revenue
5. Early Stage VC (Series B) 28-Dec-2017 0000 0000 00000 Completed Generating Revenue
4. Grant 01-Jan-2017 00000 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 26-Jan-2016 0000 0000 000.00 Completed Generating Revenue
2. Accelerator/Incubator $5M Completed Generating Revenue
1. Seed Round 19-Mar-2015 $5M $5M 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Pear Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A 24,002,981 $0.000100 8% $0.92 $0.92 1x $0.92 34.95%
To view this company’s complete Cap Table, request access »

Pear Therapeutics Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ayogo Venture Capital-Backed Vancouver, Canada 00 00.000 000000000000 00.000
00000000000 Venture Capital-Backed Taipei, Taiwan 0 000.00 00000000000 000.00
0000 00 0000000 Venture Capital-Backed Gurgaon, India 00 0000000000 0
00000 Venture Capital-Backed New York, NY 00 000.00 0000000000 0 000.00
000000000 Venture Capital-Backed Montreal, Canada 00 00.000 000000000 00.000
To view this company’s complete list of competitors, request access »

Pear Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Blue Water Life Science Fund Hedge Fund Minority 000 0000 000000 0
Trustbridge Partners Growth/Expansion Minority 000 0000 000000 0
EDBI Venture Capital Minority 000 0000 000000 0
Novartis Corporation Minority 000 0000 000000 0
Temasek Holdings Sovereign Wealth Fund Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Pear Therapeutics Executive Team (13)

Name Title Board
Seat
Contact
Info
Corey McCann Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Christopher Guiffre JD Chief Operating Officer & Chief Financial Officer
Alex Waldron Chief Commercial Officer
Jeremy Gilbert Chief Product Officer
Stephen Smith JD Co-Founder & Executive Vice President of Corporate Development

4 Former Executives

You’re viewing 5 of 13 executives. Get the full list »

Pear Therapeutics Board Members (12)

Name Representing Role Since Contact
Info
Andrew Schwab 5AM Ventures Board Member 000 0000
Corey McCann Ph.D Pear Therapeutics Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Delaine Cheong Temasek Holdings Board Observer 000 0000
Hu Hongjie Temasek Holdings Board Member 000 0000
Jamil Beg 5AM Ventures Board Observer 000 0000

2 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »